CGEN insider buying & filings

CGENCOMPUGEN LTD

NasdaqCM · Healthcare · $246.28M

$2.60

7 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jul 30 · scanned 10m ago

No price data yet — the yfinance scanner hasn't produced bars for CGEN.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$246.28M

Float

92.7M

98% public

Short % float

Pro

Price / profit

7.2

Price / future profit

—

Price / sales

3.3

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jul 30GRANTLevine ZuritSVP, Business Developmentdirect18,000 sh—

Jul 30GRANTSilberman DavidChief Financial Officerdirect19,500 sh—

Jul 30GRANTLivnat Savitzky KinneretDirectordirect7,500 sh—

Jul 30GRANTHukkelhoven MathiasDirectordirect7,500 sh—

Jul 30GRANTHalevy GileadDirectordirect7,500 sh—

Context

Wall St

$4.60 avg target

+76.9% vs today · 5 analysts

▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice